Publication Date:
1981-09-18
Description:
A covalent conjugate of an alpha-amanitin azo derivative and a monoclonal immunoglobulin G to the Thy 1.2 antigen on murine T lymphocytes was synthesized. The conjugate was 375- to 750-fold more inhibitory to murine T lymphoma S49.1 cells than the unconjugated derivative. At 0.7 X 10(-7) to 1.5 X 10(-7) M and at 4 X 10(-7) M amanitin equivalents, the conjugate inhibited protein synthesis in S49.1 cells by 50 percent and 80 to 96 percent, respectively. At these concentrations, mutant Thy l-deficient S49 cells and other murine lymphoma lacking Thy l altogether or carrying Thy 1.1 antigens were unaffected. This result demonstrated the potential for targeting amanitin to specific cell types.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Davis, M T -- Preston, J F 3rd -- R01 CA 19043/CA/NCI NIH HHS/ -- New York, N.Y. -- Science. 1981 Sep 18;213(4514):1385-8.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6115471" target="_blank"〉PubMed〈/a〉
Keywords:
Amanitins/*administration & dosage
;
Amino Acids/metabolism
;
Animals
;
Antibodies/administration & dosage
;
Antibodies, Monoclonal
;
Antigens, Surface/*immunology
;
Antigens, Thy-1
;
Cells, Cultured
;
Clone Cells/immunology
;
Hybrid Cells/immunology
;
Immunoglobulin G/*administration & dosage
;
Lymphoma/*drug therapy
;
Membrane Proteins/*immunology
;
Mice
;
Neoplasms, Experimental/drug therapy
;
T-Lymphocytes/drug effects
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
